P1–104: Assessing the effects of memantine in APP/PS1 transgenic mice by behavioral studies and ex vivo imaging of amyloid plaques using gadolinium labeled amyloid β peptides and micromri | Zendy

Wisniewski Thomas | Zendy; Scholtzova Henrieta | Zendy; Wadghiri Youssef Z. | Zendy; Sigurdsson Einar M. | Zendy; Douadi Moustafa | Zendy; Li Yongsheng | Zendy; Quartermain David | Zendy; Banerjee Pradeep K. | Zendy

Premium

P1–104: Assessing the effects of memantine in APP/PS1 transgenic mice by behavioral studies and ex vivo imaging of amyloid plaques using gadolinium labeled amyloid β peptides and micromri

Author(s) -

Wisniewski Thomas,

Scholtzova Henrieta,

Wadghiri Youssef Z.,

Sigurdsson Einar M.,

Douadi Moustafa,

Li Yongsheng,

Quartermain David,

Banerjee Pradeep K.

Publication year - 2006

Publication title -

alzheimer's and dementia

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 6.713

H-Index - 118

eISSN - 1552-5279

pISSN - 1552-5260

DOI - 10.1016/j.jalz.2006.05.480

Subject(s) - memantine , ex vivo , genetically modified mouse , nmda receptor , neuroprotection , pharmacology , in vivo , neurotoxicity , amyloid (mycology) , barnes maze , medicine , amyloid precursor protein , chemistry , pathology , alzheimer's disease , transgene , endocrinology , receptor , toxicity , biology , in vitro , biochemistry , disease , hippocampus , spatial learning , microbiology and biotechnology , gene

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research